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INTRODUCTION
 With increasing number of diagnostic and 
therapeutic procedures being performed on 
children and increased awareness about the 
presence of procedure related anxiety and pain, the 
demand for sedation and analgesia is increasing. 
Main aim of Procedural sedation and analgesia 
(PSA) is to reduce fear and anxiety of child, obtain 
their cooperation, induce unawareness and achieve 
immobilization to allow a necessary procedure 
to be performed, while keeping the child safe.1 
PSA is well established medical discipline in 
developed countries. There is however, limited 
data from Pakistan. We carried out this hospital 
based study to enhance our understanding about 
optimal application and safety of PSA in the local 
population.
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ABSTRACT
Background and Objective: Procedural sedation and analgesia (PSA) is pharmacologically induced state 
which allows patients to tolerate painful procedures while maintaining protective reflexes. It is the standard 
of care but there is limited data from Pakistan. Our objective was to assess the safety of the procedural 
sedation and analgesia in pediatric population at a tertiary care setting.
Methods: A retrospective notes and record review was  conducted at the Aga Khan University Hospital, 
Karachi over 4 years from April 2010 to August 2014. Patients were between ages 6 months to 16 years and 
were in low risk category. The combination of Ketamine and Propofol were used. Data collected on the 
standardized hospital PSA form. All procedures were performed by two trained persons.
Results: A total of 3489 diagnostic and therapeutic procedures were performed. Satisfactory level of 
sedation was achieved for 3486 (99%) of procedures. Adverse events occurred in 21 (0.6%) patients 
including: 12 (0.3%) episodes of hypoxia, 07 (0.2%) episodes of apnea, 02 (0.06%) episodes of post sedation 
hallucination. No major events were  noted.
Conclusion: Procedural sedation & analgesia for children using Propofol and Ketamine is found safe and 
effective in our setting.
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METHODS
 Study conducted at the Aga Khan University 
Hospital, Karachi after obtaining institutional ethics 
committee review board’s approval. Retrospective 
chart review was  done over a period of 4 years 
from April 2010 to August 2014. Study population 
included children between ages 6 month to 16 years 
who received PSA for various indications. PSA 
was performed at various locations outside the 
operating room environment within the hospital. 
All procedures were performed in accordance with 
American society of Anaesthesiology guidelines 
(ASA).1 Patients with ASA physical status Class I 
and II who are considered suitable candidates for 
PSA were included in study.1,2 Informed written 
consent was obtained from parents before each 
procedure. Sedation team comprised of an intensive 
care physician and a trained sedation nurse. 
Physician typically oversaw drug administration, 
while the assistant nurse continuously monitored 
the patient for complications and documented all 
the relevant information.
 Two drug combinations was used for all 
procedure; Ketamine & Propofol. Ketamine was 
given in dose of 0.5-1 mg/kg via slow IV push. This 
was followed by intra-venous Propofol initially in 
the dose of 1-2 mg/kg titrated till the patient was 
sedated. Pulse oximeter was attached and oxygen 
was administered in all cases. The procedure was 
initiated with monitoring of patient throughout 
the procedure and until complete recovery from 
effects of sedation. A PSA form was used to record 
pertinent clinical and demographic characteristics 
of patients, information related to the procedure, 
vital signs and the occurrence of complications. 
Simple descriptive statistics were used.
Definition & Outcomes
Success of sedation: defined as successful 
completion of the procedure. 
Sedation failure: defined as inability to achieve 
adequate sedation with optimal drug dosage
Complications were defined as:
• Apnea: Temporary suspension of breathing for 
greater than 20 second duration
• Hypoxia: Sustained pulse oximetry saturation 
<90% for greater than 1 minute duration
• Cardiac Arrest: Requirement of 
Cardiopulmonary resuscitation 
• Hallucination or emergence reactions: 
Perception in the absence of external stimulus 
like seeing movement or hearing noises, a loss 
of sense of time and orientation
• Allergic Reactions: Presence of rashes, itching, 




 During 4 years, 3489 diagnostic and therapeutic 
procedures were performed using PSA in 3233 
children. 2199 (68 %) patients were male. Among 
age category 26 patients (0.8%) were < 1 year of 
age, 1127 (34.8 %) were between 1 year to 5 years 
and 2080 (64.3 %) were between 6 to 16 years old. 
Descriptive characteristics and indications for PSA 
are mentioned in Table-I and II respectively. Most 
common indication was oncological procedures. 
Satisfactory level of sedation was achieved for 3486 
(99%) of the procedures. Sedation failure occurred 
only in 3 (0.08 %) patients. Adverse events occurred 
in 21 (0.6 %) patients, including: 12 (0.3%) episodes 
of hypoxia, 7 (0.2%) episodes of apnea and 2 (0.06%) 
episodes of post sedation hallucination. There were 
no major events, no recorded episodes of cardiac 
arrest or other emergencies requiring endotracheal 
intubation. Complications were managed with 
simple interventions, like hypoxia resolved after 
re-positioning of airways and increasing oxygen 
inhalation. Apneic episodes required brief bag and 
mask ventilation. Hallucination resolved after child 
became fully awake.
Table-I: Descriptive characteristics of 
Procedural Sedation & Analgesia.
Characteristics Number / (%)
Total no of patients  3233
Gender 
 M ale 2199 (68)
 Female  1034 (32)
Age
 < 1 year 26 (0.8)
 1-5 year 1127 (34.8)
 6-16 year 2080 (64.3)
Total no. of procedures 3489
Procedural Area
 Pediatrics ward procedure room 2614 (74.9)
 Daycare oncology unit 745 (21.3)
 Radiology department 107 (3.06)
 Neurophysiology department 19 (0.54)
 Endoscopy suite 04 (0.11)
 Successful procedure 3486 (99)
 Sedation failure 03 (0.08)
 Adverse effects  21 (0.60)
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DISCUSSION
 PSA is an evolving field in patient care, with 
increasing demand for performance of diagnostic 
and therapeutic procedures in safer and pain and 
anxiety free environment.1,3 Advantages include 
involvement of non-specialist care providers (non-
anaesthetists), performance outside operation 
theatres thereby saving cost, and reduction of time-
to-treatment.
 Different medications or combinations can be 
adopted for provision of PSA. In our setting we used 
the combination of Propofol and Ketamine because 
of the synergistic effects of these medications 
with each other and because of reduction in dose 
requirement as demonstrated by several studies.4 
Additional advantage of this combination strategy 
is reduction in adverse risks associated with either 
Propofol and Ketamine. For example hypotension 
and respiratory depression caused by Propofol 
can be reduced with increases in circulatory 
catecholamine surge induced by ketamine. 
Similarly, nausea and emergence reactions 
associated with Ketamine can be decreased by the 
antiemetic and anxiolytic properties of Propofol. 
Multiple studies have supported this practice.4-6
 Safety is, of course, the utmost concern. Patients 
with ASA class I and II are considered appropriate for 
PSA.1,2 As it is difficult to predict how an individual 
child will respond to a specific medication, the 
practitioner must be able to manage potential 
complications.2 In our setting PSA providers have 
resuscitation and advanced paediatric life support 
skills, as well as specific training in paediatric 
procedural sedation.
 Failed or inadequate sedation can lead to patient 
and parental anxiety, procedure cancellation, 
possible delays in diagnosis, treatment and financial 
losses. The reported incidence of inadequate or 
failed sedation ranges between 3 – 16 %.2,7 In our 
setting, sedation failure was negligible (0.08 %) 
patients.
 Multiple large studies have shown that when 
used properly, drugs used for PSA have low 
rates of complications, manageable with simple 
manoeuvres. Reported adverse events range from 
0.6% to 7.8%.2,7,10. Adverse events encountered in 
our study were 0.6%. These were mostly respiratory 
adverse events; appear to be consistent with other 
published studies.2
CONCLUSION
 Safe and effective sedation and analgesia 
is a critical skill which requires expertise and 
competency in training. Currently only few 
centres of Pakistan are utilizing this service .Our 
data suggests that PSA is safe and acceptable, 
given that stringent standards of care are met and 
established protocols are strictly followed. Minimal 
complication rates and successful achievement of 
sedation and analgesia shown by the record review 
may encourage other clinicians to adopt PSA in 
their setting.
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